NCT06596837 (VRZPB) is a NA clinical trial of virtual reality in Burns, sponsored by Martin Zielina.

Who is sponsoring NCT06596837?

NCT06596837 is sponsored by Martin Zielina.

What drugs are being tested in NCT06596837?

Interventions in NCT06596837: virtual reality.

What condition does NCT06596837 study?

NCT06596837 studies Burns, Virtual Reality, Anxiety, Pain.

Is NCT06596837 still recruiting?

NCT06596837 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT06596837: VRZPB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality and Coping with Procedural Pain in Burn Patients

Completed NA Last updated 19 September 2024

What this trial tests

NA trial testing virtual reality in Burns in 71 participants. Completed in 4 August 2023.

Timeline

15 September 2021

Primary endpoint
1 May 2022

4 August 2023

Quick facts

Lead sponsor	Martin Zielina
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	71
Start date	15 September 2021
Primary completion	1 May 2022
Estimated completion	4 August 2023
Sites	1 location across Czechia

Drugs / interventions tested

virtual reality

Conditions studied

Burns — all drugs for Burns →
Virtual Reality — all drugs for Virtual Reality →
Anxiety — all drugs for Anxiety →
Pain — all drugs for Pain →

Sponsor

Martin Zielina

Who can join

18 and older, any sex, with Burns or Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the project is to reduce the feeling of procedural pain (when changing bandages) in burn patients through a developed and pilot-verified application for virtual reality (hereinafter VR). The first study on this topic was conducted in the US on two pediatric patients. In addition to pharmacological pain therapy, there are a number of non-pharmacological options (eg, relaxation techniques) that are based on distracting attention from the feeling of pain. VR appears to be the most promising of these options and, in addition to distraction, it also reduces anxiety and depressive symptoms and enhances patient cooperation. The studies also agree on the beneficial role of immersivity; a sense of immersion in VR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of virtual reality

Trials testing the same drug.

NCT07293221 — Immersive Virtual Reality for the Management of Anxiety Among Nurses · NA · recruiting
NCT07499011 — Comparison Between Virtual Reality and Stress Ball Intervention In Managing Pain During Episiotomy Repair · NA · completed
NCT07005271 — VR Hand Exercises: Impact on Cognition and Dexterity in MCI · NA · completed
NCT07195981 — VIRTUAL REALITY IN CERVICAL RADICULOPATHY PATIENTS · NA · completed
NCT07004101 — Effect of Virtual Reality Combined With Balance Training on Biodex Balance System in Female With Fibromyalgia · NA · active not recruiting

Other recruiting trials for Burns

Currently open trials in the same condition.

NCT07259668 — Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns · recruiting
NCT07248930 — Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns · recruiting
NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter · NA · recruiting
NCT07142824 — Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing · NA · recruiting
NCT07277166 — The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function Af · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06596837 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Martin Zielina
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06596837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing